Skip to main content
Fig. 7 | Cancer Nanotechnology

Fig. 7

From: Emodin-loaded polymer-lipid hybrid nanoparticles enhance the sensitivity of breast cancer to doxorubicin by inhibiting epithelial–mesenchymal transition

Fig. 7

E-PLNs increase the accumulation of DOX by inhibiting the expression of drug resistance protein. A, B The accumulation of in MCF-7/ADR cells treated with DOX, DOX + EMO, DOX + E-PLNs measured by flow cytometry. C, D The expression of P-gp in MCF-7/ADR cells detected by Western blotting analysis. N = 3, **p < 0.01, ***p < 0.001 compared with DOX group

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us